Centre issues Letter of Comfort to Bharat Biotech for 4.5 mn Covaxin doses

. Bharat Biotech said it has also donated 16.5 lakh doses to the Government of India. Sources further said the supplies from the company depend on the orders being placed by the government

Coronavirus, vaccine, covid, drugs, clinical trials
The doses will be dispatched as when the Ministry places orders with the company.
Press Trust of India Hyderabad
1 min read Last Updated : Jan 19 2021 | 12:09 PM IST

Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 4.5 million doses of its Covid-19 vaccine, Covaxin, sources said.

Out of the 4.5 millioon doses, the city-based vaccine maker will be supplying over 800,000 to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as good will gesture sources added.

"The company was given a fresh letter of comfort recently for supplying another 4.5 million doses of Covaxin.

The doses will be dispatched as when the Ministry places orders with the company," sources told PTI.

After having received the government purchase order for 5.5 million doses, BharatBiotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow, it said.

Bharat Biotech said it has also donated 1.65 million doses to the Government of India.

Sources further said the supplies from the company depend on the orders being placed by the government.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusBharat BiotechCoronavirus Vaccine

First Published: Jan 19 2021 | 11:59 AM IST

Next Story